Tait D Shanafelt, MD - Medicare Hematology in Stanford, CA

Tait D Shanafelt, MD is a medicare enrolled "Internal Medicine - Hematology" physician in Stanford, California. He went to University Of Colorado School Of Medicine, Denver and graduated in 1998 and has 26 years of diverse experience with area of expertise as Hematology. He is a member of the group practice Stanford Health Care and his current practice location is 300 Pasteur Dr, Stanford, California. You can reach out to his office (for appointments etc.) via phone at (650) 723-4000.

Tait D Shanafelt is licensed to practice in California (license number C149730) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1295712677.

Contact Information

Tait D Shanafelt, MD
300 Pasteur Dr,
Stanford, CA 94305-2200
(650) 723-4000
Not Available



Physician's Profile

Full NameTait D Shanafelt
GenderMale
SpecialityHematology
Experience26 Years
Location300 Pasteur Dr, Stanford, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Tait D Shanafelt attended and graduated from University Of Colorado School Of Medicine, Denver in 1998
  NPI Data:
  • NPI Number: 1295712677
  • Provider Enumeration Date: 12/28/2005
  • Last Update Date: 04/16/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 2163472630
  • Enrollment ID: I20171206002828

Medical Identifiers

Medical identifiers for Tait D Shanafelt such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1295712677NPI-NPPES
632660900MedicaidMN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RX0202XInternal Medicine - Medical Oncology C149730 (California)Secondary
207RH0000XInternal Medicine - Hematology C149730 (California)Primary
207R00000XInternal Medicine C149730 (California)Secondary
207RH0003XInternal Medicine - Hematology & Oncology 44085 (Minnesota)Secondary
207RH0003XInternal Medicine - Hematology & Oncology C149730 (California)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Stanford Health CareStanford, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Stanford Health Care67097974912572

News Archive

Potential treatment target identified for fatty liver disease

Two proteins, p38 gamma and p38 delta, control the accumulation of fat in the liver, a process linked to the development of insulin resistance and diabetes, which are common outcomes of obesity. These findings are presented in an article published by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC).

Experts discuss PEPFAR funding in congressional hearing

At a recent hearing of the House Subcommittee on Africa and Global Health, "[i]nternational health organisations working to help check the spread of AIDS in Africa said meagre increases in funds from the U.S. government this year would be a step backwards. Some experts also emphasised that prevention must get appropriate attention in any fight against the disease," Inter Press Service reports.

Findings suggest development of 'post-infection' vaccine to reduce TB rates in China

A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next few decades, requiring a refocus in efforts to control a disease affecting millions of people in the country, according to preliminary new research presented today at the Fourth Global Forum on TB Vaccines in Shanghai.

Wellstar International commences second Beta Test in Long Term Care Facility

Wellstar International Inc. has announced they have started their second Beta Test in a Long Term Care Facility.

Caraco enters into a consent decree with the FDA regarding its drug manufacturing operations

Caraco Pharmaceutical Laboratories, Ltd. announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug manufacturing operations. The decree provides a series of measures that, when satisfied, will permit Caraco to resume manufacturing and distributing those products that are manufactured in its Detroit area facilities.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Tait D Shanafelt allows following entities to bill medicare on his behalf.
Entity NameStanford Health Care
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437292927
PECOS PAC ID: 6709797491
Enrollment ID: O20031124000348

News Archive

Potential treatment target identified for fatty liver disease

Two proteins, p38 gamma and p38 delta, control the accumulation of fat in the liver, a process linked to the development of insulin resistance and diabetes, which are common outcomes of obesity. These findings are presented in an article published by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC).

Experts discuss PEPFAR funding in congressional hearing

At a recent hearing of the House Subcommittee on Africa and Global Health, "[i]nternational health organisations working to help check the spread of AIDS in Africa said meagre increases in funds from the U.S. government this year would be a step backwards. Some experts also emphasised that prevention must get appropriate attention in any fight against the disease," Inter Press Service reports.

Findings suggest development of 'post-infection' vaccine to reduce TB rates in China

A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next few decades, requiring a refocus in efforts to control a disease affecting millions of people in the country, according to preliminary new research presented today at the Fourth Global Forum on TB Vaccines in Shanghai.

Wellstar International commences second Beta Test in Long Term Care Facility

Wellstar International Inc. has announced they have started their second Beta Test in a Long Term Care Facility.

Caraco enters into a consent decree with the FDA regarding its drug manufacturing operations

Caraco Pharmaceutical Laboratories, Ltd. announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug manufacturing operations. The decree provides a series of measures that, when satisfied, will permit Caraco to resume manufacturing and distributing those products that are manufactured in its Detroit area facilities.

Read more Medical News

› Verified 2 days ago

Entity NameLpch Medical Group Div Of Lucile
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1417907940
PECOS PAC ID: 0840298543
Enrollment ID: O20061113000232

News Archive

Potential treatment target identified for fatty liver disease

Two proteins, p38 gamma and p38 delta, control the accumulation of fat in the liver, a process linked to the development of insulin resistance and diabetes, which are common outcomes of obesity. These findings are presented in an article published by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC).

Experts discuss PEPFAR funding in congressional hearing

At a recent hearing of the House Subcommittee on Africa and Global Health, "[i]nternational health organisations working to help check the spread of AIDS in Africa said meagre increases in funds from the U.S. government this year would be a step backwards. Some experts also emphasised that prevention must get appropriate attention in any fight against the disease," Inter Press Service reports.

Findings suggest development of 'post-infection' vaccine to reduce TB rates in China

A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next few decades, requiring a refocus in efforts to control a disease affecting millions of people in the country, according to preliminary new research presented today at the Fourth Global Forum on TB Vaccines in Shanghai.

Wellstar International commences second Beta Test in Long Term Care Facility

Wellstar International Inc. has announced they have started their second Beta Test in a Long Term Care Facility.

Caraco enters into a consent decree with the FDA regarding its drug manufacturing operations

Caraco Pharmaceutical Laboratories, Ltd. announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug manufacturing operations. The decree provides a series of measures that, when satisfied, will permit Caraco to resume manufacturing and distributing those products that are manufactured in its Detroit area facilities.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tait D Shanafelt is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Tait D Shanafelt, MD
300 Pasteur Dr,
Stanford, CA 94305-2200

Ph: (650) 723-4000
Tait D Shanafelt, MD
300 Pasteur Dr,
Stanford, CA 94305-2200

Ph: (650) 723-4000

News Archive

Potential treatment target identified for fatty liver disease

Two proteins, p38 gamma and p38 delta, control the accumulation of fat in the liver, a process linked to the development of insulin resistance and diabetes, which are common outcomes of obesity. These findings are presented in an article published by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC).

Experts discuss PEPFAR funding in congressional hearing

At a recent hearing of the House Subcommittee on Africa and Global Health, "[i]nternational health organisations working to help check the spread of AIDS in Africa said meagre increases in funds from the U.S. government this year would be a step backwards. Some experts also emphasised that prevention must get appropriate attention in any fight against the disease," Inter Press Service reports.

Findings suggest development of 'post-infection' vaccine to reduce TB rates in China

A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next few decades, requiring a refocus in efforts to control a disease affecting millions of people in the country, according to preliminary new research presented today at the Fourth Global Forum on TB Vaccines in Shanghai.

Wellstar International commences second Beta Test in Long Term Care Facility

Wellstar International Inc. has announced they have started their second Beta Test in a Long Term Care Facility.

Caraco enters into a consent decree with the FDA regarding its drug manufacturing operations

Caraco Pharmaceutical Laboratories, Ltd. announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug manufacturing operations. The decree provides a series of measures that, when satisfied, will permit Caraco to resume manufacturing and distributing those products that are manufactured in its Detroit area facilities.

Read more News

› Verified 2 days ago


Internal Medicine Doctors in Stanford, CA

Prista Charuworn, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 300 Pasteur Dr, Alway Build M211, Mc 5187, Stanford, CA 94305
Phone: 650-723-6661    
Yu Kuang Lai, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 300 Pasteur Dr, Stanford, CA 94305
Phone: 650-723-4000    
Andrea Lorenze, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 300 Pasteur Drive, Lane 154, Stanford, CA 94305
Phone: 650-723-6661    Fax: 650-498-6205
Audra Horomanski, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 300 Pasteur Dr, Stanford, CA 94305
Phone: 650-723-4000    Fax: 650-498-6205
Meghan Brady Marmor, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 300 Pasteur Dr, Stanford, CA 94305
Phone: 650-723-4000    
Lauren Michelle Ulsh, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 300 Pasteur Dr, Stanford, CA 94305
Phone: 650-723-4000    
Ann M Chen, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 300 Pasteur Dr, A149, Mc5202, Stanford, CA 94305
Phone: 650-725-3376    Fax: 650-723-8305

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.